Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Public Health Nutr. 2014 May 27;18(5):916–926. doi: 10.1017/S1368980014001062

Table 6. Associations between cancer variables and any use of vitamin C, vitamin E and/or calcium over the lifetime among participants of the databank and biorepository at a comprehensive cancer centre in western New York, USA, December 2003–July 2012.

Men Women


OR 95% CI OR 95% CI
Cancer status
 Controls 100 Reference 100 Reference
 Patients 0.86 0.70, 1.05 0.88 0.78, 1.00
Cancer type§
 Benign 100 Reference 100 Reference
 New 0.83 0.63, 1.10 0.87 0.72, 1.05
 Recurrent 1.37 0.93, 2.02 0.84 0.59, 1.21
Cancer site§
 Breast 0.83 0.28, 2.42 1.04 0.89, 1.21
 Prostate 1.17 0.97, 1.42 N/A
 Respiratory 1.02 0.77, 1.35 0.99 0.75, 1.32
 Gastrointestinal 0.83 0.65, 1.07 0.83 0.64, 1.07
 Gynaecological N/A 0.99 0.82, 1.18
 Genitourinary 0.86 0.66, 1.11 0.99 0.82, 1.18
 Skin 0.99 0.67, 1.46 1.36 0.91, 2.03
 Others 1.05 0.80, 1.38 1.04 0.80, 1.39
Cancer stage††
In situ 100 Reference 100 Reference
 Localized 1.20 0.52, 2.80 0.81 0.59, 1.11
 Regional 0.90 0.38, 2.12 0.73 0.52, 1.02
 Distant 0.98 0.41, 2.32 0.75 0.52, 1.08
 Unknown 1.15 0.48, 2.75 0.80 0.53, 1.22

N/A, not applicable.

Adjusted for age, race, education, family history of cancer, smoker status, BMI, total fruit and vegetable intake, physical activity.

Overall n 8096 (men=2787; women =5309).

§

Cancer patients only (overall =5418: men =2145; women =3273).

Odds ratio compared with all other cancer sites or stages.

Odds ratio compared with all previously reported cancer sites.

††

Cancer patients with malignancies (overall =4494: men =1890; women =2604).